Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01515813

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

A Randomized Controlled Trial to Compare the Effects of Highly Active Antiretroviral Therapy (HAART) Versus Statin Therapy on Endothelial Function and Markers of Inflammation/Coagulation In HIV-Infected Individuals With High CD4 Cell Counts

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Since people started taking HIV medications, illnesses related to AIDS have decreased, but other serious illnesses like heart disease (heart attacks) and certain kinds of cancer have increased. Studies show that HIV causes changes in the lining of the arteries and also causes inflammation (irritation) inside the body that may play a role in diseases like heart attacks and strokes. The levels of inflammation and artery lining health can also affect how well your brain works. These changes cannot be felt, but can be measured. Artery lining health can be looked at with a test that uses a blood pressure cuff on your arm to see how the artery responds when air is let in and out of the cuff. An ultrasound (machine that uses sound waves) is used to look at the artery during the test. This test is called Flow Mediated Dilation or FMD for short. Inflammation can be checked with blood tests (blood tests that measure this irritation inside the body that you cannot feel). HIV medications can improve the artery lining health and can partially lower levels of inflammation in the blood; however, these levels of inflammation may not be able to return back to normal. Pravastatin sodium is a medication that is approved by the Food and Drug Administration (FDA) for treating high cholesterol. Pravastatin sodium has also been able to improve the health of the lining of the arteries and lower the level of inflammation in people with other diseases, but has not been studied or approved for this purpose in people who have HIV. This research study will look at the effects of two types of medications used separately or together on the health of the lining of arteries and levels of inflammation in the blood: Atripla (a HIV medication) and pravastatin sodium. This study will also look at the effects of Atripla and pravastatin sodium on cholesterol levels, tests that measure how well you can think and calculate (tests of neurocognitive function), and at the effects of Atripla on the levels of pravastatin sodium in the blood.

Conditions

Interventions

TypeNameDescription
DRUGPravastatin sodiumOne 40 mg tablet of Pravastatin sodium taken orally once daily.
DRUGEfavirenz/Emtricitabine/Tenofovir Disoproxil FumarateParticipant will be administered one tablet of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF)600 mg/200 mg/300 mg taken orally once daily
DRUGPravastatin sodiumTwo 40mg tablets (80 mg total) of Pravastatin sodium taken orally once daily.

Timeline

Start date
2011-11-01
Primary completion
2014-07-01
Completion
2014-12-01
First posted
2012-01-24
Last updated
2016-02-01

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01515813. Inclusion in this directory is not an endorsement.